Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
operating since 1894
Headquarter in London and 5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Employment test 1 - 10 employees
Company dna avidity ip ltd
no operation time available
1125.78
Headquarter in Cambridge and 3 offices
active in Legal Services

We have observed 11 EP applications James Christopher Legg has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13195379

Methods of monitoring conditions by sequence analysis

IPC classification:
C12Q 1/68, C12N 15/10
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12843478

BIOMARKERS OF CANCER

IPC classification:
G01N 33/50, C12Q 1/68, A61P 35/00
Applicant:
Massachusetts General Hospital
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14163571

Nucleic acid quantitation from tissue slides

IPC classification:
C12Q 1/68, C12N 15/10
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
The patent has been granted
EP12844825

T-CELL RECEPTOR CLONOTYPES SHARED AMONG ANKYLOSING SPONDYLITIS PATIENTS

IPC classification:
A61K 39/395, C12Q 1/68, C12N 15/12, C07K 16/18
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
PATENT GRANTED
EP12854963

METHOD OF MEASURING IMMUNE ACTIVATION

IPC classification:
C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12856834

DETECTION AND MEASUREMENT OF TISSUE-INFILTRATING LYMPHOCYTES

IPC classification:
C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12812999

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

IPC classification:
C12N 15/74, C12N 9/22, C07K 14/195
Applicant:
Wageningen University and Research Centre (Wageningen Universiteit)
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13738391

NANOPORE BASED MOLECULAR DETECTION AND SEQUENCING

IPC classification:
G01N 27/414, G01N 27/26, C12Q 1/68
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13748712

METHODS FOR CREATING BILAYERS FOR USE WITH NANOPORE SENSORS

IPC classification:
C12Q 1/68, C12N 15/11
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13749460

POLYMERASE ENZYME SUBSTRATES WITH PROTEIN SHIELD

IPC classification:
C12Q 1/68, C12N 15/54, C12N 9/10, C12M 1/38
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
The patent has been granted
EP13751112

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

IPC classification:
A61K 38/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature